DIETARY INGREDIENTS

Subscribe to DIETARY INGREDIENTS via RSS

FDA Allows Allulose to be Excluded From Sugar Declarations

Posted on April 19, 2019

On April 18, 2019, FDA released a draft guidance for industry entitled, “The Declaration of Allulose and Calories from Allulose on Nutrition and Supplement Facts Labels.” The guidance

…
Continue Reading FDA Allows Allulose to be Excluded From Sugar Declarations

FDA Announces New Tool to Alert the Public of Unlawful Ingredients in Dietary Supplements

Posted on April 17, 2019

As our readers may remember, earlier this year the FDA announced a plan for modernizing and strengthening dietary supplement regulation and oversight. Under the plan, the FDA stated their

…
Continue Reading FDA Announces New Tool to Alert the Public of Unlawful Ingredients in Dietary Supplements

FDA Announces Public Meeting to Solicit Comments on Regulation of Dietary Supplements

Posted on April 12, 2019

The Dietary Supplement Health and Education Act of 1994 (DSHEA) amended the Food, Drug, and Cosmetic Act to create the current regulatory framework for dietary supplements. At the time the

…
Continue Reading FDA Announces Public Meeting to Solicit Comments on Regulation of Dietary Supplements

Stakeholder Comments Reflect Discontent with FDA’s Draft Guidance for Quantitative Labeling of Supplements Containing Live Microbials

Posted on November 12, 2018

FDA’s regulation on nutrition labeling of dietary supplements requires that dietary ingredients for which a Reference Daily Intake (RDI) or Daily Reference Value (DRV) has not been established must be

…
Continue Reading Stakeholder Comments Reflect Discontent with FDA’s Draft Guidance for Quantitative Labeling of Supplements Containing Live Microbials

FDA Renews Cautions Against Consumption of Kratom Following Conclusion of Salmonella Investigation

Posted on July 5, 2018

Kratom is a botanical substance that grows naturally in Southeast Asia. FDA classifies kratom as an opioid, noting that it is addictive and has been linked to severe health consequences

…
Continue Reading FDA Renews Cautions Against Consumption of Kratom Following Conclusion of Salmonella Investigation

FDA oversees destruction and recall of kratom products

Posted on February 22, 2018

On February 21, FDA issued a press release announcing the voluntary destruction and recall of a large volume of kratom-containing dietary supplements manufactured and distributed nationwide under the brand names

…
Continue Reading FDA oversees destruction and recall of kratom products

FDA Announces October Meeting on Pre-DSHEA List

Posted on September 6, 2017

Manufacturers or distributors of new dietary ingredients (NDIs) must submit a pre-market notification called a new dietary ingredient notification (NDIN) to FDA at least 75 days before marketing a dietary

…
Continue Reading FDA Announces October Meeting on Pre-DSHEA List

Supplement Spotlight: FDA Revised NDI Draft Guidance Does Not Alleviate Industry’s Concerns

Posted on January 17, 2017

As previously reported on this blog, FDA issued a revised Draft Guidance titled, “Dietary Supplements: New Dietary Ingredient [NDI] Notifications and Related Issues,” in August 2016. The Agency received…
Continue Reading Supplement Spotlight: FDA Revised NDI Draft Guidance Does Not Alleviate Industry’s Concerns

Supplement Spotlight: FDA Revises NDI Draft Guidance

Posted on August 11, 2016

FDA issues long-awaited revised Draft Guidance on new dietary ingredient notifications (NDINs) for dietary supplements.

The Dietary Supplement Health and Education Act (DSHEA) requires the manufacturer or distributor of a

…
Continue Reading Supplement Spotlight: FDA Revises NDI Draft Guidance

Supplement Registry Update

Posted on July 6, 2016

Leading dietary supplement trade association makes strides in developing product registry.

As previously covered on this blog, a leading dietary supplement trade association — the Council for Responsible Nutrition

…
Continue Reading Supplement Registry Update

menu

The Daily Intake